{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:56:28Z","timestamp":1792792588752,"version":"4.5.0"},"reference-count":26,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Global Blood Therapeutics","id":[{"id":"https:\/\/ror.org\/03cr60k70","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.1080\/17474086.2022.2031967","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T06:01:31Z","timestamp":1645509691000},"page":"167-173","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":35,"title":["Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis"],"prefix":"10.1080","volume":"15","author":[{"given":"Nirmish","family":"Shah","sequence":"first","affiliation":[{"name":"Division of Hematology, Division of Pediatric Hematology\/Oncology, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thokozeni","family":"Lipato","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, VCU Health, Richmond, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofelia","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, University of Miami, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Delea","sequence":"additional","affiliation":[{"name":"Policy Analysis Inc. (PAI), Brookline, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0203-2762","authenticated-orcid":false,"given":"Alexander","family":"Lonshteyn","sequence":"additional","affiliation":[{"name":"Policy Analysis Inc. (PAI), Brookline, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5405-2215","authenticated-orcid":false,"given":"Derek","family":"Weycker","sequence":"additional","affiliation":[{"name":"Policy Analysis Inc. (PAI), Brookline, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Global Blood Therapeutics, South San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Beaubrun","sequence":"additional","affiliation":[{"name":"Global Blood Therapeutics, South San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Agodoa","sequence":"additional","affiliation":[{"name":"Global Blood Therapeutics, South San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"cit0001","unstructured":"Centers for Disease Control and Prevention [Internet]. Data and statistics on sickle cell disease cited 2021 Aug 18. Available from: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.10"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30193-9"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510865"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1177\/003335491312800206"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.378"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.01.001"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26758"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fds035"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.625"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2019.12.007"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14346"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14383"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141706"},{"key":"cit0015","unstructured":"Oxbryta [prescribing information]. South San Francisco (CA): Global Blood Therapeutics, Inc. 2021 January."},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.6b00491"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14214"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903212"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00059-4"},{"key":"cit0020","unstructured":"Symphony Health [Internet]. Fact Sheet. Key IDV Statistics. 2020 cited 2021 Sep 2. Available from: https:\/\/s3.us-east-1.amazonaws.com\/prahs-symphony-health\/resources\/Symphony_IDV-Sheet_FINAL_JULY.pdf?mtime=20200702132440%26focal=none *\n                      This reference provides publicly available background information on the Symphony database."},{"key":"cit0021","unstructured":"Fingar K, Owens P, Reid L, et al. Characteristics of inpatient hospital stays involving sickle cell disease, 2000-2016. HCUP statistical brief #251 [Internet]. September 2019. [cited 2019 Oct 2]. Available from: https:\/\/hcup-us.ahrq.gov\/reports\/statbriefs\/sb251-Sickle-Cell-Disease-Stays-2016.jsp"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1177\/2040620720955000"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.3233\/CH-170340"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139529"},{"issue":"8","key":"cit0025","first-page":"CD012082","volume":"8","author":"Fortin P","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21443"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2022.2031967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T10:48:12Z","timestamp":1649674092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2022.2031967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"alternative-id":["10.1080\/17474086.2022.2031967"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2022.2031967","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}